Xencor Inc - 03 Sep 2021 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Reporting relationship: 10%+ Owner
Issuer ticker: INMB
Reported as of: 03 Sep 2021
Net transaction value: +$842,400
SEC form: 4
Accepted by SEC: 08 Sep 2021, 16:15:28 UTC
Prior SEC filing: 08 Sep 2021
Source filing: View source filing
Reporting owner signature: /s/ John J. Kuch

Key filing fact

Xencor Inc filed Form 4 for Inmune Bio, Inc. (INMB) on 08 Sep 2021.

Key facts

This page summarizes Xencor Inc's Form 4 filing for Inmune Bio, Inc. (INMB).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Sep 2021, 16:15.

Change

Previous filing in this sequence was filed on 08 Sep 2021.
Current net transaction value: +$842,400.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INMB transaction

Common Stock

Options Exercise

Transaction value: $842,400
Shares: +108,000
Change %: +6.1%
Price: $7.80
Shares after: 1,885,533
Date: 03 Sep 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INMB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -108,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Sep 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 108,000
Exercise price: $7.80
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option vested in 36 equal monthly installments beginning on April 3, 2018.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .